Company Profiles

driven by the PitchBook Platform

Alexo Therapeutics

Description

Developer of protein-based therapeutics for cancer treatment. The company develops protein-based therapeutics with anticancer antibodies that helps immune system to eradicate cancer from the patients system.

2015

Founded

PRIVATE

Status

Series A

Latest Deal Type

$23.1M

Latest Deal Amount

$23.1M

Total Amount Raised

4

Investors

Description

Developer of protein-based therapeutics for cancer treatment. The company develops protein-based therapeutics with anticancer antibodies that helps immune system to eradicate cancer from the patients system.

Website:

www.alexotherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

951 Gateway Boulevard Suite 201 South San Francisco, CA 94080United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Alexo Therapeutics's full profile, request a free trial.

    Alexo Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Alexo Therapeutics Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Irish Venture Capital AssociationVenture CapitalMinority000 0000000 0000
    Lightstone VenturesVenture CapitalMinority000 0000000 0000
    SPARK ScholarsAccelerator/IncubatorMinority000 0000000 0000
    venBioVenture CapitalMinority000 0000000 0000
    Irish Venture Capital Association Venture Capital
    Lightstone Ventures Venture Capital
    SPARK Scholars Accelerator/Incubator
    venBio Venture Capital

    Alexo Therapeutics Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Jaume Pons Ph.DChief Executive Officer, Board Member, President and Co-Founder
    John BorgesonChief Financial Officer
    Hong Wan Ph.DChief Scientific Officer
    Hank SternVice President, Chemistry, Manufacturing & Controls
    Michael ChangVice President, Operations
    Jaume Pons Ph.D Chief Executive Officer, Board Member, President and Co-Founder
    John Borgeson Chief Financial Officer
    Hong Wan Ph.D Chief Scientific Officer
    Hank Stern Vice President, Chemistry, Manufacturing & Controls
    Michael Chang Vice President, Operations

    Alexo Therapeutics Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Corey GoodmanAlexo TherapeuticsChairman of the Board000 0000
    Jason LettmanAlexo TherapeuticsBoard Member000 0000
    Jason LettmannLightstone VenturesGeneral Partner000 0000
    Jaume Pons Ph.DAlexo TherapeuticsChief Executive Officer, Board Member, President and Co-Founder000 0000
    K. GarciaAlexo TherapeuticsBoard Observer & Board Member000 0000
    Corey Goodman Chairman of the Board Alexo Therapeutics
    Jason Lettman Board Member Alexo Therapeutics
    Jason Lettmann General Partner Lightstone Ventures
    Jaume Pons Ph.D Chief Executive Officer, Board Member, President and Co-Founder Alexo Therapeutics
    K. Garcia Board Observer & Board Member Alexo Therapeutics
    Request full access to PitchBook